CPP, ceruloplasmin pseudogene, 340451

N. diseases: 55; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.050 Biomarker group BEFREE In vivo experiments conducted with tumor bearing nude Balb/c mice confirm the efficacy of Cu@CPP-800 as a very promising NIR-driven phototherapy agent for cancer treatment. 31788959 2020
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.050 Biomarker group BEFREE Finally, reduced tumour size was also observed upon T-cell depletion in CPP-bearing mice. 31142360 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.050 Biomarker group BEFREE We present a case of an infant with CPP and significant diffuse leptomeningeal contrast enhancement at diagnosis, which spontaneously resolved after removal of the primary tumor. 30617713 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.050 Biomarker group BEFREE In conclusion; prepared CPP-targeted dendrimeric formulations of SN38 exhibited efficient characteristics in tumor inhibitory. 30991135 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.050 Biomarker group BEFREE The sequential delivery vesicles showed the anticipated three-layered TEM structure and dual-convertible (surface charge- and particle size-reversible) features in the tumor environment (pH 6.5), which guaranteed the sequential release of siVEGF-CPPs and PTX in the tumor extracellular environment and tumor cells, respectively. 30144476 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE Confocal microscopy imaging revealed the surprising response of FaDu cell to COL/CPP in comparison to previously studied cancer cell lines: hybrid peptides that carry both COL and CPP domain adsorb on the FaDu cell surface. 30769789 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.030 Biomarker group BEFREE Confocal microscopy imaging revealed the surprising response of FaDu cell to COL/CPP in comparison to previously studied cancer cell lines: hybrid peptides that carry both COL and CPP domain adsorb on the FaDu cell surface. 30769789 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE Here we show that upon illumination with near-infrared (NIR) light, both VHH<sup>[PS]</sup> and VHH<sup>[PS]</sup>-CPP conjugates specifically induce cell death of EGFR expressing cancer cell lines and of EGFR-expressing cells derived from surgically obtained ascites from patients with high-grade serous ovarian cancer. 29274374 2018
CUI: C0030193
Disease: Pain
Pain
0.030 Biomarker phenotype BEFREE The scores in all sleep dimensions of the MOS-sleep were higher in CPP (more disturbances) compared to pain free patients, and differences were observed among the three groups of PCP, with FM most severely affected. 28945136 2018
CUI: C0030193
Disease: Pain
Pain
0.030 Biomarker phenotype BEFREE Three main groups of women with CPP were identified: Cluster 1 (n = 35) had moderate severity of pain, with poor average and present pain intensity; Cluster 2 (n = 14) had a long duration of symptoms/diagnosis, the worst current pain and worst physical, emotional and social functions; Cluster 3 (n = 11) had the shortest duration of pain and showed the best evidence of coping with low (good) physical, social and emotional scores. 29310639 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.030 Biomarker group BEFREE Here we show that upon illumination with near-infrared (NIR) light, both VHH<sup>[PS]</sup> and VHH<sup>[PS]</sup>-CPP conjugates specifically induce cell death of EGFR expressing cancer cell lines and of EGFR-expressing cells derived from surgically obtained ascites from patients with high-grade serous ovarian cancer. 29274374 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.030 Biomarker group BEFREE In total, 11% of all patients received a cancer diagnosis after completing a diagnostic course in the NSSC-CPP; the most common types were breast cancer (18%) hematopoietic and lymphoid tissue cancer (15%), and malignant melanoma (12%). 28807680 2017
CUI: C0030193
Disease: Pain
Pain
0.030 Biomarker phenotype BEFREE Treatment with systemic morphine abolished CPP to saphenous nerve block, demonstrating control of ongoing pain. 28438966 2017
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.030 Biomarker group BEFREE In total, 11% of all patients received a cancer diagnosis after completing a diagnostic course in the NSSC-CPP; the most common types were breast cancer (18%) hematopoietic and lymphoid tissue cancer (15%), and malignant melanoma (12%). 28807680 2017
CUI: C0003467
Disease: Anxiety
Anxiety
0.020 Biomarker disease BEFREE In Experiment 3, 2 mg/kg <i>m</i>-CPP or saline was administered to adult hens previously habituated to the open field arena to pharmacologically validate an attention bias test as a measure of anxiety. 31333910 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.020 Biomarker group BEFREE In Experiment 3, 2 mg/kg <i>m</i>-CPP or saline was administered to adult hens previously habituated to the open field arena to pharmacologically validate an attention bias test as a measure of anxiety. 31333910 2019
CUI: C0011432
Disease: Dentin Sensitivity
Dentin Sensitivity
0.020 Biomarker disease BEFREE After one-month follow-up, the association of CPP-ACPF with PBM was effective in the reduction of DH and promoted a positive impact on the HRQL of the participants of this study. 31790452 2019
CUI: C0011432
Disease: Dentin Sensitivity
Dentin Sensitivity
0.020 GeneticVariation disease BEFREE The application of CPP-ACP paste during at-home tooth bleaching with 20% CP was beneficial since its use reduced the TS and presented no deteriorating effect on the colour change. 30121734 2019
CUI: C0043154
Disease: Dental White Spot
Dental White Spot
0.020 Biomarker disease BEFREE Thirty-six artificial WSLs samples were created and randomly assigned to three treatments: artificial saliva solution (negative control, n = 12), casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) slurry (n = 12), and PAA-ACP@aMSN slurry (n = 12). 31705307 2019
CUI: C0043154
Disease: Dental White Spot
Dental White Spot
0.020 Biomarker disease BEFREE The application of CPP-ACP and CPP-ACPF had a significant regenerative effect on the WSLs. 31116280 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.020 Biomarker disease BEFREE The behavior analysis showed that m-CPP (2 mg/kg and 4 mg/kg) could induce anxiety behaviors in the mice while diazepam (2 mg/kg) reversed the anxiety behavior induced by m-CPP. 29545208 2018
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.020 Biomarker group BEFREE The behavior analysis showed that m-CPP (2 mg/kg and 4 mg/kg) could induce anxiety behaviors in the mice while diazepam (2 mg/kg) reversed the anxiety behavior induced by m-CPP. 29545208 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.020 Biomarker disease BEFREE Ce6-AuNR@SiO<sub>2</sub>-d-CPP demonstrated a robust efficacy in the treatment of breast cancer by photothermal/photodynamic therapy. 30555230 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.020 Biomarker disease BEFREE Ce6-AuNR@SiO<sub>2</sub>-d-CPP demonstrated a robust efficacy in the treatment of breast cancer by photothermal/photodynamic therapy. 30555230 2018
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.020 GeneticVariation disease BEFREE In total, 11% of all patients received a cancer diagnosis after completing a diagnostic course in the NSSC-CPP; the most common types were breast cancer (18%) hematopoietic and lymphoid tissue cancer (15%), and malignant melanoma (12%). 28807680 2017